van den Brand et al. (2017)

Summary of novel genes

Entity Tier 1 genes Tier 2 genes
MZL 2
--- config: sankey: showValues: true linkColor: target width: 300 height: 300 nodeAlignment: right prefix: '(' suffix: ' genes)' --- sankey-beta This study, MZL Tier 1, This study, MZL Tier 2, 2 Other MZL studies, MZL Tier 1, 42 Other MZL studies, MZL Tier 2, 74

Novel genes reported in this study

New gene MZL tier
CD9B 2
TNIP2 2

Details

Brand, Michiel van den, Jos Rijntjes, Konnie M. Hebeda, Laura Menting, Carolyn V. Bregitha, Wendy B. C. Stevens, Walter J. F. M. van der Velden, Bastiaan B. J. Tops, J. Han J. M. van Krieken, and Patricia J. T. A. Groenen. 2017. “Recurrent Mutations in Genes Involved in Nuclear Factor-κB Signalling in Nodal Marginal Zone Lymphoma-Diagnostic and Therapeutic Implications.” Histopathology 70 (2): 174–84. https://doi.org/10.1111/his.13015.

Citing

If you use the information or data from this site, please cite

Krysta Coyle, Kostiantyn Dreval, Daniel Hodson and Ryan D. Morin. Audit of B-cell cancer genes. Blood Adv (2025) 9 (8): 2019–2031.

Disclaimer

The content in these pages has been populated, in part, by an automated process. Although we have scrutinized every page to ensure accuracy, errors will inevitably exist. If you find an error please report it as an issue and we will address it.

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

Share — copy and redistribute the material in any medium or format for any purpose, even commercially.

Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.